Hongbo Lu, Director at Turning Point Therapeutics, Inc. (TPTX), bought 1,180,730 shares at $18.00 ($1.1M) on 2019-04-22, disclosed to the SEC on 2019-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,120,730 | $0 | 0.0% |
| 2 | $18.00 | 60,000 | $1.1M | 100.0% |
| Total | $0.91 avg | 1,180,730 | $1.1M | 100% |
| Filing → |
| ZBIO | BUY | 2026-03-31 | $1.5M | — | Filing → |
| ZBIO | BUY | 2026-02-13 | $585K | — | Filing → |
| ZBIO | BUY | 2025-10-09 | $5.0M | — | Filing → |